Johnson & Johnson
14:47 :
Boston Scientific claims patent victory -
Boston Scientific Corp said today the US District Court for the District of New Jersey ruled in its favour, finding all patents in a suit brought by Johnson & Johnson to be invalid.
16:19 :
Exclusive - Banks tap firms for cash -
LONDON (Reuters) - Blue-chip names like Johnson & Johnson,
Pfizer and Peugeot are among firms bailing out Europe's ailing banks in a reversal of the established roles of clients and lenders.
22:05 :
Buffett faults J&J's use of stock in Synthes deal -
OMAHA, Neb., April 30 (Reuters) - Warren Buffett criticized Johnson & Johnson , a large investment for his company Berkshire Hathaway Inc , for using too much of its own stock in a planned $21.7 billion takeover of Swiss medical ...
08:16 :
Johnson & Johnson to buy Synthes for $21.3bn -
Deal to buy Swiss medical devices maker is J&J's biggest everJohnson & Johnson is to buy Swiss medical devices maker Synthes in a deal worth $21.3bn (£14bn), its largest ever buy, boosting its orthopaedics franchise and reshaping the medical technology ...
06:37 :
J&J says to buy Synthes for $21.3 billion -
ZURICH (Reuters) - Johnson & Johnson is to buy Swiss medical devices maker Synthes Inc in a deal worth $21.3 billion (12.9 billion pounds), its largest ever buy, boosting its orthopaedics franchise and reshaping the medical technology ...
16:36 :
Looking for a Band-Aid: Johnson & Johnson -
It will take more than a deal, even a $20 billion one, to fix Johnson & JohnsonEvery child knows the tactic. When you are in trouble over one thing, cause a stir over another. On April 15th the Wall Street Journal reported that Johnson & Johnson|Johnson ...
03:59 :
Johnson & Johnson targets Synthes bid -
Swiss medical firm Synthes confirmed yesterday that it's in talks regarding a possible takeover by drug giant Johnson & Johnson (J&J) in a move that's likely to value the company at as much as €15bn.
21:50 :
Deal could be cure for Johnson & Johnson -
A successful bid for Synthes, the Swiss medical device maker, could be timely medicine for Johnson & Johnson after a year plagued by product recalls and bribery allegations
20:44 :
J&J leaps amid Swiss talks reports -
Johnson & Johnson shares jumped in after-hours trading on reports that the US healthcare company was in talks to acquire Synthes, a Swiss medical device maker in a deal valued at about $20bn
16:19 :
J&J in talks to buy Synthes for $20 billion - source -
BOSTON (Reuters) - Johnson & Johnson is in preliminary talks to acquire Swiss medical device maker Synthes for a price which could be about $20 billion (12 billion pounds), a source familiar with the situation said on Saturday.
actualidad Johnson & Johnson -